tagline 2001
Addthis
- Tenofovir (Viread), First Novel Antiviral Agent in Six Years, Approved by FDA
- Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV
- Patent Politics: Nongovernmental Organization Access Effort Dealt Stealth Blow By Ivy League Development Institute
- Down the Pike: Argentina International AIDS Society Conference Snoozer Prompts Systematic Review of Drug Pipeline
- Coming, Going and Gone: The Drug Development Pipeline, 2001
- Breaking It Down: Investigational New Drugs Currently Being Tested In Humans, By Class
- Shreds of Evidence: Shudda, Cudda, Wudda -- Reevaluating the Treatment Revolution After the Fall
- Strike Two: Model Physician/Patient Pair Are Latest to Feel the Fury of Fragile, Unforgiving Treatment Plan
- Drug Economy: Antiretroviral Renegade Fights Fashion With Didanosine Duo, Betting His Future on Genetic Barriers
- Human Leukocyte Antigens (HLA) and HIV Disease Progression
- Vaccine Vitriol: Call for Poor Country Focus on Treatment, Care Programs Elicits Voice of Concern from Vaccine Outfit
- African Epistle: Outrage, Indifference Greet Plans for Worldwide Treatment Agenda -- As Millions More Die
- Stalled in the Gates: The Not So Accelerated Access Initiative
- Diabolic Duo: End Stage Liver Disease Emerges As Leading Cause of Death in PWAs with Hepatitis C
- Farewell to Arms: Government Experts Roll Back the Big Guns, And Slither Away to Trenches
- Mary Jean Slugs It Out in Gaithersburg: Roche’s Valganciclovir is Recommended for Approval
- Needleless Retinitis Therapy With FDA Approval of Oral CMV Drug
- FDA Discusses Trial Design for Salvage Therapy
- Brazil 1, Merck 0: The Cost of Generic Drugs in Brazil
- Vaccine Advance: Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway
- Open Letter to Pharma Execs
- March 5th: Day of Global Direct Action for Drug Access
- Pendulum Swing: Treatment Paradigms Come and Go, But the Virus and Its Problematic Potions Appear Intractable
- Simian Success: Vaccine Study Seen as Significant Advance, But Questions Remain About Human Applicability
- Early Indications of What "The Accidental President" Might Do for AIDS